1. Blagburn, B.L., Hendrix, C.M., Vaughan, J.L., Lindsay, D.S., Tebbit, G.L., 1995. Efficacy of a chewable formulation of milbemycin oxime against preadult Dirofilaria immitis and adult Ancylostoma caninum in naturally and experimentally infected dogs. In: Soll, M.D. (Ed.), Proceedings of the Heartworm Symposium’95. American Heartworm Society, Washington, DC, pp. 171–175.
2. Calvert, C.A., Rawlings, C.A., McCall, J.W., 1994. Feline heartworm disease. In: Sherding, R.G. (Ed.), The Cat: Diseases and Clinical Management, 2nd Edition. Churchill Livingstone, New York, pp. 623–645.
3. CVM, 1992. Conduct of clinical investigations: responsibilities of clinical investigators and monitors for investigational new animal drug studies. Technical Report, October. Center for Veterinary Medicine, Rockville, MD.
4. CVM, 1997. Good target animal study practices: clinical investigators and monitors. Technical Report, May. Center for Veterinary Medicine, Rockville, MD.
5. Courtney, C.H., Zeng, Q.Y., 1989. The structure of heartworm populations in dogs and cats in Florida. In: Otto, G.F. (Ed.), Proceedings of the Heartworm Symposium’89. American Heartworm Society, Washington, DC, pp. 1–6.